CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018	Jun. 30, 2018	Mar. 31, 2018
Statement of Cash Flows [Abstract]
Provision for Doubtful Accounts	$ 428			$ 620
Cash flows from operating activities:
Net income	19,456			2,069
Adjustments to reconcile net income to cash provided by operating activities:
Loss from discontinued operations, net of tax	(273)			0
Depreciation and amortization	44,106			44,455
Long-lived asset impairment	3,092			4,710
Inventory write-downs	222			465
Amortization of operating lease ROU assets	712			0
Amortization of deferred financing costs	1,509			1,585
Amortization of debt discount	366			344
Amortization of terminated interest rate swaps	0			184
Interest rate swaps	(410)			257
Stock-based compensation expense	2,357			1,794
(Gain) loss on sale of assets	16			(1,195)
Deferred income tax provision (benefit)	(2,883)			295
Amortization of contract costs	5,117			2,884
Deferred revenue recognized in earnings	(12,749)			(5,171)
Changes in assets and liabilities:
Accounts receivable, trade	(3,154)			4,539
Inventory	3,724			(1,187)
Other assets	15,165			601
Contract costs	(6,574)			(8,078)
Accounts payable and other liabilities	1,131			8,091
Deferred revenue	9,467			5,395
Other	29			(202)
Net cash provided by operating activities	81,400			62,455
Cash flows from investing activities:
Capital expenditures	(132,697)			(69,972)
Proceeds from sale of property, plant and equipment	11,155			14,845
Proceeds from insurance	238			136
Net cash used in investing activities	(121,304)			(54,991)
Cash flows from financing activities:
Proceeds from borrowings of long-term debt	690,000			155,830
Repayments of long-term debt	(629,000)			(146,636)
Payments for debt issuance costs	(7,521)			(2,316)
(Payments for) proceeds from settlement of interest rate swaps that include financing elements	393
(Payments for) proceeds from settlement of interest rate swaps that include financing elements				(205)
Dividends to Archrock stockholders	(17,231)	$ (17,156)	$ (15,486)	(8,532)
Distributions to noncontrolling partners in the Partnership	0			(11,766)
Proceeds from stock issued under our employee stock purchase plan	218			223
Purchases of treasury stock	(857)			(1,041)
Net cash provided by (used in) financing activities	36,002			(14,443)
Net decrease in cash and cash equivalents	(3,902)			(6,979)
Cash and cash equivalents at beginning of period	5,610		$ 3,557	10,536
Cash and cash equivalents at end of period	$ 1,708	$ 5,610		$ 3,557